11th CARDIOVASCULAR DISEASE UPDATE

11th Cardiovascular Disease Update

WEDNESDAY, OCTOBER 4, 2017

4:30 – 6 p.m.      Registration and Reception
                             Innovations in Health Care Exhibit from Cleveland Institute of Art

6 – 9:20 p.m.      Dinner and CME Presentations

Landerhaven
6111 Landerhaven Drive
Mayfield Heights, Ohio 44124

OVERVIEW

Featuring specialists with University Hospitals Harrington Heart & Vascular Institute, this course takes a closer look at current topics in cardiovascular medicine and surgery, including new guidelines, clinical trials and the latest research findings and discoveries. Our experts examine the potential benefits and risks of these developments, and explore how they might impact patient care.

LEARNING OBJECTIVES

  • Review indications for common structural interventions and when to refer patients
  • Define complications with transcatheter aortic valve replacement (TAVR) and follow-up care
  • Review new therapies to lower risk in the diabetic patient with peripheral artery disease (PAD)
  • Explain the impact and longevity of new therapies for critical limb ischemia (CLI)
  • Describe advanced imaging options for evaluation of heart failure patients
  • Discuss indications for mechanical therapies, including durability and efficacy, for heart failure

WHO SHOULD ATTEND

This conference is intended to update practicing internists, family medicine physicians, primary care physicians, cardiologists, cardiac surgeons, endocrinologists, podiatrists, vascular surgeons, physician assistants, nurse practitioners, nurses, residents and fellows on current topics in cardiovascular disease.

ACCREDITATION STATEMENT

Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Case Western Reserve University School of Medicine designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

POLICY DISCLOSURE

The policy of Case Western Reserve University School of Medicine CME Program requires that the Activity Director, planning committee members and all activity faculty (that is, anyone in a position to control the content of the education activity) disclose to the activity participants all relevant financial relationships with commercial interests. Disclosure will be made to activity participants prior to the commencement of the activity. Case Western Reserve University School of Medicine CME Program also requires that faculty make clinical recommendations based on the best available scientific evidence and that faculty identify any discussion of “off-label” or investigational use of pharmaceutical products or medical devices.

VIEW THE AGENDA

ONLINE REGISTRATION INFORMATION